BioPharma Drive: Drug Pricing

DECEMBER 12, 2023

The deal signals the pharma company’s continuing interest in vaccine development and hands it a combination shot aimed at two respiratory viruses.

Vaccine 196

Vaccine Pharma Companies Virus 196

The Pharma Data

NOVEMBER 27, 2020

This week, another pharma company revealed a new technology device that can detect if a patient is infectious or not, while the Russian government published results of its Sputnik V vaccine, claiming it is more than 95 per cent efficient 42 days after the first dose. Read on to for the full insight.

Vaccine 52

Vaccine Virus International Immune Response 52

The Pharma Data

DECEMBER 11, 2020

The collaborating entities have claimed that having quantitative data on neutralizing antibodies would enable a better understanding of a person’s immune response following exposure to the Covid-19 virus and would support monitoring the effectiveness of vaccines available to the UK population.

Vaccine 52

Vaccine Immune Response Pharma Companies Virus 52

The Pharma Data

OCTOBER 16, 2020

As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. With many nationwide and regional lockdowns coming into force, virtual clinical trials are proving to be an effective way to monitor patients remotely.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Clinical Research 52

Codon

FEBRUARY 13, 2024

Tom Ireland writes about the companies and technologies that are reimagining phage therapy. Over time, this dynamic leads to many, slightly different strains of both virus and host. Read it on our website here. Illustration by David S. Goodsell, RCSB Protein Data Bank and Scripps Research.

Therapies 135

Therapies Virus DNA Clinical Trials 135

The Pharma Data

DECEMBER 23, 2020

Given the massive pandemic caused by SARS-CoV-2, a virus with almost identical genetic sequence and similar in pathogenesis to the first SARS virus with persuasive emerging evidence supporting COVID-19’s SARS-CoV-2 induced chronic fatigue is following a similar pattern. If successful, this may change millions of lives for the better.”.

Clinical Trials 52

Clinical Trials Trials Virus Therapies 52

The Pharma Data

NOVEMBER 20, 2020

Pharma leaders fear extreme vulnerability in end-to-end supply chain as pandemic continues, according to global survey. Explore how pharma companies and industry leaders can reset for growth in the lab beyond coronavirus in Pharma IQ ’s fourth annual edition of Smart Lab Digital. Save your early bird seat now.

Pharma Companies 52

Pharma Companies Vaccine Drugs Pharmacy 52